D530-0401 Screening compound: 2-[5,7-bis(4-methylphenyl)-4H,7H-[1,2,3,4]tetrazolo[1,5-a]pyrimidin-4-yl]-N-butylacetamide

D530-0401 Screening compound: 2-[5,7-bis(4-methylphenyl)-4H,7H-[1,2,3,4]tetrazolo[1,5-a]pyrimidin-4-yl]-N-butylacetamide
D530-0401 Screening compound: 2-[5,7-bis(4-methylphenyl)-4H,7H-[1,2,3,4]tetrazolo[1,5-a]pyrimidin-4-yl]-N-butylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound D530-0401
2-[5,7-bis(4-methylphenyl)-4H,7H-[1,2,3,4]tetrazolo[1,5-a]pyrimidin-4-yl]-N-butylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D530-0401

Molecular Formula

C24H28N6O (C24 H28 N6 O)

Compound Name

2-[5,7-bis(4-methylphenyl)-4H,7H-[1,2,3,4]tetrazolo[1,5-a]pyrimidin-4-yl]-N-butylacetamide

IUPAC name

2-[57-bis(4-methylphenyl)-4H7H-[1234]tetrazolo[15-a]pyrimidin-4-yl]-N-butylacetamide

SMILES

CCCCNC(CN1C(c2ccc(C)cc2)=CC(c2ccc(C)cc2)n2nnnc12)=O

InChI

InChI=1S/C24H28N6O/c1-4-5-14-25-23(31)16-29-21(19-10-6-17(2)7-11-19)15-22(30-24(29)26-27-28-30)20-12-8-18(3)9-13-20/h6-13,15,22H,4-5,14,16H2,1-3H3,(H,25,31)/t22-/m1/s1

InChI Key

ISTDKWSMSCSGNI-JOCHJYFZSA-N

MDL Number (MFCD)

MFCD27591537

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

416.53

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.721

Distribution Coefficient, logD

4.721

Water Solubility, LogSw

-4.34

Polar Surface Area

65.181

Acid Dissociation Constant (pKa)

15.03

Base Dissociation Constant (pKb)

0.56

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

33.30

D530-0401 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with D530-0401 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound D530-0401?
Check Price and Availability of D530-0401, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of D530-0401 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for D530-0401
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for D530-0401
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of D530-0401 available by request